INTERESTING COMPANIES FOUND
RoverMed Biosciences (2016, Minnetonka) – Developing therapeutics for solid cancers using its Crystalline Ultra-Small Particle (CUSP) technology. Its CUSP technology can deliver the drugs into the cell nucleus regardless of cell’s location.
HIGHLIGHTS OF THE DAY
- Mystery biotech Emmaus grabs groundbreaking FDA panel backing for sickle cell drug — after quietly scrapping $225M deal. Read More
- Harpoon Therapeutics raises $45M Series B for taking Immuno-Onco drug to trials. Read More
- NEJM paper buoys GW Pharma as it eyes FDA filing for cannabis drug Epidiolex. Read More
- Promising Glaucoma trial results push Aerie Pharma 39% higher. Read More
- Merck moves from amyloid to Tau, in-licenses Teijin Pharma’s antibody candidate. Read More